Showing results (91-100 of 220) with videos related to
Sort By:
Pageof 22
Gastroenterology|January 24, 2007
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitisStefan Schreiber, Ali Keshavarzian, Kim L Isaacs, et al.Inflammatory Bowel Diseases|February 23, 2013
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease centerAtsushi Sakuraba, Kian Keyashian, Chase Correia, et al.The American Journal of Gastroenterology|July 24, 2002
Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United StatesWilliam J Tremaine, Stephen B Hanauer, Seymour Katz, et al.The New Zealand Medical Journal|March 12, 2026
Correlation between patient-determined inflammatory bowel disease severity and the inflammatory bowel disease severity indexAndrew Mark McCombie, Corey A Siegel, Stephen B Hanauer, et al.Inflammatory Bowel Diseases|March 1, 2005
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileumKeri A Kles, Stephan R Vavricka, Jerrold R Turner, et al.Inflammatory Bowel Diseases|July 27, 2022
Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for ChangeTiffany H Taft, Josie McGarva, Tina A Omprakash, et al.Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|October 12, 2023
Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control studyTina Aswani-Omprakash, Madhura Balasubramaniam, Josie McGarva, et al.Journal of Clinical Psychology in Medical Settings|July 22, 2021
Patient Perspectives on Medical Trauma Related to Inflammatory Bowel DiseaseKimberly Pothemont, Sarah Quinton, Majdoline Jayoushe, et al.The American Journal of Gastroenterology|July 2, 2009
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysisLaurent Peyrin-Biroulet, Pierre Deltenre, Sandro Ardizzone, et al.Gut|January 30, 2014
Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trialFreddy Cornillie, Stephen B Hanauer, Robert H Diamond, et al.Pageof 22